STML

Artal Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-360,000	Closed	-$3.83M	–	115
2019 Q4	$3.83M	Hold	360,000	–	–	0.15%	69
2019 Q3	$3.75M	Hold	360,000	–	–	0.15%	69
2019 Q2	$5.52M	Sell	360,000 -40,000	-10%	-$613K	0.22%	64
2019 Q1	$5.14M	Hold	400,000	–	–	0.21%	59
2018 Q4	$3.8M	Hold	400,000	–	–	0.14%	51
2018 Q3	$6.64M	Hold	400,000	–	–	0.17%	44
2018 Q2	$6.42M	Hold	400,000	–	–	0.14%	42
2018 Q1	$6.12M	Buy	400,000 +200,000	+100%	+$3.06M	0.08%	38
2017 Q4	$3.12M	Sell	200,000 -50,000	-20%	-$780K	0.05%	49
2017 Q3	$2.78M	Hold	250,000	–	–	0.05%	55
2017 Q2	$2.3M	Buy	250,000 +150,000	+150%	+$1.38M	0.04%	66
2017 Q1	$855K	Buy	+100,000	New	+$855K	0.02%	68
2014 Q4	–	Sell	-170,000	Closed	-$2.12M	–	84
2014 Q3	$2.12M	Hold	170,000	–	–	0.08%	39
2014 Q2	$2.49M	Buy	170,000 +15,000	+10%	+$220K	0.1%	34
2014 Q1	$3.16M	Sell	155,000 -15,000	-9%	-$305K	0.11%	33
2013 Q4	$3.33M	Buy	+170,000	New	+$3.33M	0.12%	25